Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Scand J Immunol ; 70(1): 53-62, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19522768

ABSTRACT

Lacrimal epithelial cells appear to constitutively secrete autoantigens to their underling stroma. The present experiments address the hypothesis that they also secrete soluble factors that regulate immune responses. Epithelial cells, spleen cells and lymphocytes were obtained from rabbits or rats and cultured in various configurations. Monocytes from rat bone marrow were matured to dendritic cells (DC) ex vivo. Proliferation was measured by [3H]-thymidine incorporation; surface MHC Class II and CD86 using flow cytometry; and mRNA relative abundances using real time RT-PCR. Microporous culture inserts containing rat lacrimal cells inhibited proliferation of rabbit lymphocytes co-cultured with autologous lacrimal cells and of rat lymphocytes co-cultured with TNF-alpha-stimulated DC. They inhibited CD86 and MHC Class II surface expression by maturating DC and reversed surface expression of CD86 but not MHC Class II by partially matured DC. Subsequent exposure of partially matured DC to mediators from rat lacrimal cells reversed the ability to stimulate lymphocyte proliferation. TGF-beta(1) and IL-10 mRNAs increased somewhat when rat lacrimal cells were isolated but decreased markedly in rabbit lacrimal cells. Antibodies to TGF-beta prevented soluble factors from rat lacrimal cells from inhibiting proliferation of rabbit lymphocytes co-cultured with rabbit lacrimal cells, but recombinant TGF-beta alone did not mimic the soluble factors. IL-10 immunopositivity was detected in epithelial cells of interlobular ducts and occasional interstitial cells in rabbit lacrimal gland. Rat lacrimal epithelial cells secrete TGF-beta and other factors that synergize to suppress lymphocyte proliferation and regulate DC maturation. Interlobular duct epithelial cells in rabbit lacrimal glands may express similar functions.


Subject(s)
Dendritic Cells/physiology , Epithelial Cells/immunology , Immunologic Factors/immunology , Lacrimal Apparatus/immunology , Animals , B7-2 Antigen/biosynthesis , Cell Proliferation , Coculture Techniques , Female , Flow Cytometry , Histocompatibility Antigens Class II/biosynthesis , Immunohistochemistry , Interleukin-10/biosynthesis , Interleukin-10/immunology , Lacrimal Apparatus/cytology , Lymphocyte Activation/immunology , Lymphocytes , Male , Phenotype , Rabbits , Rats , Rats, Inbred Lew , Reverse Transcriptase Polymerase Chain Reaction , Transforming Growth Factor beta1/biosynthesis , Transforming Growth Factor beta1/immunology
2.
J Fr Ophtalmol ; 27(5): 479-83, 2004 May.
Article in French | MEDLINE | ID: mdl-15179303

ABSTRACT

INTRODUCTION: The Authors report the case of a 50-Year-old man with myotonic dystrophy, who developed severe bilateral capsulorhexis contracture after uneventful cataract surgery. OBSERVATION: Phacoemulsification was performed in both eyes with implantation of intraocular lenses. The patient came to complain of decreased vision in both eyes (4/10 Parinaud 4). Visual acuity initially improved after surgery to 8/10 P2 in each eye. After 7 months for the right eye and 3 Months for the left eye, the patient presented with dramatically reduced vision, caused by a severe capsulorhexis contracture. Anterior capsulotomies with the Nd:YAG laser were performed in both eyes to treat this complication. It was sufficient on the left eye but the right eye required a surgical anterior capsulectomy to remove the IOL and the bag and put in an Artisan lens. DISCUSSION: Capsulorhexis contracture results from fibrous metaplasia of lens epithelial cells from the anterior capsule. Myotonic dystrophy appears to predispose to the development of severe capsulorhexis contracture after phacoemulsification.


Subject(s)
Capsulorhexis , Cataract Extraction/methods , Myotonic Dystrophy/complications , Postoperative Complications/diagnosis , Contracture/etiology , Contracture/pathology , Humans , Lens Capsule, Crystalline/pathology , Lens Implantation, Intraocular , Male , Middle Aged , Postoperative Complications/surgery , Treatment Outcome
3.
Exp Eye Res ; 78(2): 257-74, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14729358

ABSTRACT

PURPOSE: To analyze the relevance of a human conjunctival cell line in a study of conjunctival epithelium. We investigated and compared the effects of IFNgamma and TNFalpha in a primary culture of human conjunctiva and in a human conjunctival cell line. METHODS: A primary-cultured human conjunctival epithelium and a human conjunctival cell line (Chang cells) were treated for 72 hr with 20, 200, 400 and 600 U ml(-1) IFNgamma or with 1100 and 11,000 U ml(-1) TNFalpha. Then, the expression of HLA DR, CD40, CD44, CD63, CD80, CD86, Fas receptor, E-cadherin, ICAM-1, MUC1, cytokeratins and vimentin were investigated by flow cytometry. Cell morphology was studied with phalloidin staining. Apoptosis was detected by flow cytometry with Annexin V and via cell cycle analysis. RESULTS: The primary culture of human conjunctival epithelium expressed cytokeratin K4, non-keratinized squamous epithelial marker. Chang cells presented a more dedifferentiated phenotype and were cytokeratin K4 negative. In primary-cultured cells, IFNgamma (600 U ml(-1)) induced only a low level of apoptosis and a significant upregulation of most tested proteins such as HLA DR, Fas, ICAM-1, CD40 and CD63. In the Chang cell line, IFNgamma induced a significant level of apoptosis at concentrations of 200, 400 and 600 U ml(-1). HLA DR and CD63 were induced at lower levels than in primary-cultured cells. Other proteins were modified in a similar manner after IFNgamma treatment in both systems. In the primary-cultured cells, TNFalpha induced an important upregulation of ICAM-1, Fas and CD40 whereas CD44 and CD63 were significantly decreased. Conversely, only a very weak alteration of CD63 and ICAM-1 was observed in the Chang cell line after TNFalpha treatment. CONCLUSIONS: A primary culture of a human conjunctival epithelium demonstrated well-defined epithelial features. TNFalpha and IFNgamma, two inflammatory cytokines, induced different effects in both cellular systems, in a primary-cultured conjunctival epithelium and a human conjunctival cell line. Inflammation-related molecules were highly upregulated in the primary culture and, to a lesser extent, in the Chang cell line. Thus, the Chang cell line differs in certain features from a primary culture of human conjunctival epithelium, a fact which emphasizes the complexity of interpretation of in vitro data and this should be taken into consideration in in vitro studies of human conjunctival epithelium.


Subject(s)
Conjunctiva/cytology , Epithelial Cells/cytology , Antigens, Surface/metabolism , Apoptosis/drug effects , Cadherins/metabolism , Cell Cycle , Cell Line , Cell Size , Cells, Cultured , Conjunctiva/drug effects , Conjunctiva/metabolism , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Eye Proteins/metabolism , Flow Cytometry , Humans , Interferon-gamma/pharmacology , Intermediate Filament Proteins/metabolism , Microscopy, Confocal , Tumor Necrosis Factor-alpha/pharmacology
5.
Invest Ophthalmol Vis Sci ; 42(11): 2525-33, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11581193

ABSTRACT

PURPOSE: Quaternary ammonium ions have been demonstrated to induce apoptosis correlated with superoxide anion production in vitro. The purpose of this study was to further investigate the mechanisms of benzalkonium chloride (BAC), unpreserved and preserved beta-blocker eye-drops-induced programmed cell death, with special attention to the roles of mitochondrial transmembrane potential and intracellular reduced glutathione. METHODS: Chang conjunctival cells were incubated with different concentrations of unpreserved or preserved timolol (0.1%, 0.25%, and 0.4%), or carteolol (1% and 2%), or BAC (0.0001% to 0.01%) for 15 minutes, or for 15 minutes with a 24-hour recovery period in normal medium. Cellular viability (neutral red test), mitochondrial activity (rhodamine 123 test), intracellular reduced glutathione (monochlorobimane test), DNA condensation (Hoechst 33342 test), and reactive oxygen species (ROS) production (dichlorofluorescein diacetate and hydroethidine tests) were evaluated using microplate cold-light cytofluorometry. RESULTS: A significant, concentration-dependent decrease in cellular viability was found with preserved beta-blockers and with BAC alone, whereas unpreserved preparations did not show any toxicity. Only preserved beta-blockers induced chromatin condensation associated with an alteration of mitochondrial activity and a decrease of glutathione, suggesting an apoptotic phenomenon. BAC increased glutathione after 15 minutes, whereas a decrease was observed after a recovery period. ROS production was found with preserved formulations at significantly higher levels than those observed with unpreserved drugs. CONCLUSIONS: This in vitro study demonstrates that oxidative stress, evidenced by enhanced ROS production and mitochondrial injury rather than by cellular glutathione depletion, is a mechanism involved in apoptosis induced by preservative-containing eye-drops.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , Apoptosis/drug effects , Benzalkonium Compounds/pharmacology , Conjunctiva/drug effects , Glutathione/metabolism , Mitochondria/physiology , Preservatives, Pharmaceutical/pharmacology , Carteolol/pharmacology , Cell Line , Cell Survival/drug effects , Conjunctiva/metabolism , DNA/biosynthesis , Dose-Response Relationship, Drug , Humans , Oxidative Stress , Reactive Oxygen Species/metabolism , Timolol/pharmacology
6.
Invest Ophthalmol Vis Sci ; 42(1): 90-5, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11133852

ABSTRACT

PURPOSE: Immune-based inflammation has been observed as a common mechanism of keratoconjunctivitis sicca (KCS). In KCS-affected eyes, upregulated expression of HLA DR and various immune- or apoptosis-related markers by conjunctival epithelial cells has been demonstrated in an earlier study, by a technique of flow cytometry in impression cytology (IC) specimens. The purpose of this study was to monitor the effects of topical cyclosporin A on the expression of these markers throughout a 6-month period of treatment. METHODS: Patients with moderate to severe KCS included in a large European multicenter clinical trial (Cyclosporin Dry Eye Study, Allergan, Irvine, CA) underwent collection of IC specimens at baseline, month 3, and month 6. For 6 months, they randomly received 0.05% or 0.1% cyclosporin A or vehicle. Specimens were processed and analyzed in a masked manner by flow cytometry, using monoclonal antibodies directed to HLA DR, CD40, CD40 ligand, Fas, and the apoptotic marker APO2.7. Percentages of positive cells were calculated and levels of expression quantified after conversion into standardized units of fluorescence. RESULTS: One hundred fifty-eight patients had at least two IC specimens available for flow cytometry analysis. HLA DR expression, both in percentage of positive cells and level of expression, was highly significantly reduced after 0.05% and 0.1% cyclosporin A treatment at months 3 and 6 compared with baseline values, whereas vehicle did not induce any change in HLA DR expression over time. The 0.05% and 0.1% cyclosporin emulsions were significantly more effective than the vehicle in reducing HLA DR at months 3 and 6 (0.05%), and at month 6 (0.1%). CD40 expression was significantly reduced at month 3 and partially at month 6, compared with baseline, with no reduction in patients who received the vehicle. CD40 ligand expression also decreased at months 3 and 6 in patients taking both concentrations of cyclosporin A. APO2.7 expression was significantly increased in all three groups, whereas percentage of Fas-positive cells decreased only in patients treated with 0.05% cyclosporin A at months 3 and 6. CONCLUSIONS: Flow cytometry provided an objective technique to monitor the effects of topical cyclosporin A on immune- and apoptosis-related markers in the conjunctival epithelium of patients with KCS enrolled in a large multicenter trial. Topical cyclosporin A strikingly reduced HLA DR and to a lesser extent, other inflammatory and apoptotic markers, whereas the vehicle, used as a control tear substitute, had almost no effect. This study confirms that cyclosporin A may be efficient in reducing conjunctival inflammation in moderate to severe KCS and is consistent with clinical results in this indication.


Subject(s)
CD40 Antigens/metabolism , CD40 Ligand/metabolism , Cyclosporine/therapeutic use , HLA-DR Antigens/metabolism , Immunosuppressive Agents/therapeutic use , Keratoconjunctivitis Sicca/drug therapy , Xenopus Proteins , fas Receptor/metabolism , Administration, Topical , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers/analysis , Cornea/drug effects , Cornea/metabolism , Cyclosporine/administration & dosage , Double-Blind Method , Female , Flow Cytometry , Homeodomain Proteins/metabolism , Humans , Immunosuppressive Agents/administration & dosage , Keratoconjunctivitis Sicca/metabolism , Male , Middle Aged , Ophthalmic Solutions/administration & dosage , Ophthalmic Solutions/therapeutic use
7.
Invest Ophthalmol Vis Sci ; 41(9): 2531-43, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10937564

ABSTRACT

PURPOSE: Previously interferon (IFN)gamma-induced apoptosis and expression of inflammation-related proteins in a human conjunctival cell line were demonstrated. The aim of this study was to further investigate the mechanisms of IFNgamma-, Fas-, and cycloheximide (CHX)-induced programmed cell death, with special attention to the role of transcriptional factors NF-kappaB and STAT1. METHODS: In a human conjunctival cell line (Chang conjunctival cells) apoptosis was induced with 500 ng/ml anti-Fas antibody (anti-Fas ab) alone (24 or 48 hours) or, as previously reported, with 300 U/ml of human recombinant IFNgamma alone (48 hours). To study the role of IFNgamma on Fas-induced apoptosis, cells were treated first with IFNgamma at 30 U/ml during 24 hours (nontoxic dose), and then anti-Fas ab was applied for 24 hours. Moreover, to study the influence of CHX on Fas- and IFNgamma-induced apoptosis, cells were treated for 24 hours with 300 U/ml IFNgamma together with a nontoxic concentration (1 microg/ml) of CHX, or with 500 ng/ml anti-Fas ab together with 1 microg/ml CHX (24 hours). After treatment, cell viability (neutral red assay), mitochondrial membrane potential (rhodamine 123 assay), chromatin condensation (Hoechst 33342 assay), and the index Hoechst/neutral red were studied by cold light microplate cytometry. The apoptotic process was sought for by contrast phase microscopy and DAPI staining and was confirmed by immunoblotting of PARP. Activation of caspase-3 (CPP32) and caspase-8 were investigated by Western blot analysis. NF-kappaB and STAT DNA-binding activities were studied by electrophoretic mobility shift assays (EMSA). RESULTS: After 24 and 48 hours of treatment with anti-Fas ab alone, 15% to 20% and 30%, respectively, of apoptotic cells were observed. When anti-Fas sera were applied after IFNgamma pretreatment or together with CHX, 50% to 80% of cells demonstrated morphologic characteristics of programmed cell death. Apoptosis was confirmed by a cleavage of PARP and CPP32, by caspase-8 activation, and by an index Hoechst/neutral red greater than one. All these modifications were preceded by a decrease in mitochondrial membrane potential. EMSA revealed that NF-kappaB was activated after IFNgamma and anti-Fas ab treatments and inhibited after CHX treatment. STAT1 was strongly activated after IFNgamma treatment and only in a minor degree after anti-Fas ab treatment. STAT1-binding activity persisted after CHX treatment. CONCLUSIONS: The relative resistance of Chang cells toward Fas-induced apoptosis could be related to the activation of NF-kappaB. IFNgamma-induced programmed cell death preferentially involves the activation of STAT1 that counterbalances NF-kappaB antiapoptotic effects. In fact, Fas-induced apoptosis was potentiated by IFNgamma or CHX treatments. These results suggest that NF-kappaB activation could maintain cell viability as well as participate in IFNgamma-induced inflammatory modifications, whereas STAT1 activation could provide, in this model, a proapoptotic signal.


Subject(s)
Apoptosis/drug effects , Conjunctiva/drug effects , Interferon-gamma/pharmacology , fas Receptor/pharmacology , Antibodies, Monoclonal/pharmacology , Blotting, Western , Caspases/metabolism , Cell Line , Cell Survival , Chromatin/drug effects , Conjunctiva/metabolism , Conjunctiva/pathology , Cycloheximide/pharmacology , DNA-Binding Proteins/metabolism , Drug Combinations , Flow Cytometry , Humans , Membrane Potentials/drug effects , Microscopy, Phase-Contrast , Mitotic Index/drug effects , NF-kappa B/metabolism , Recombinant Proteins , STAT1 Transcription Factor , Signal Transduction , Trans-Activators/metabolism , fas Receptor/immunology
8.
J Fr Ophtalmol ; 23(6): 603-5, 2000 Jun.
Article in French | MEDLINE | ID: mdl-10880928

ABSTRACT

We report a case of acute angle-closure glaucoma in a patient treated with bronchodilator nebulization. An 82-year-old man with chronic obstructive bronchopathy was treated for acute respiratory decompensation with salbutamol and ipratropium bromide aerosols. Twenty-four hours after beginning the treatment, the patient developed acute angle-closure glaucoma which resolved rapidly with appropriate treatment. The case emphasizes the importance of precautionary measures (waterproof glasses and inhalation masks). In addition patients with a high risk of angle-closure glaucoma should be detected prior to prescribing bronchodilating aerosols.


Subject(s)
Albuterol/adverse effects , Bronchodilator Agents/adverse effects , Glaucoma, Angle-Closure/chemically induced , Ipratropium/adverse effects , Acute Disease , Administration, Inhalation , Aged , Aged, 80 and over , Humans , Male
9.
Invest Ophthalmol Vis Sci ; 41(6): 1356-63, 2000 May.
Article in English | MEDLINE | ID: mdl-10798650

ABSTRACT

PURPOSE: To investigate in impression cytology (IC) specimens the expression of inflammatory and apoptosis-related markers by conjunctival epithelial cells from patients with dry eye as a rationale for treatment with topical cyclosporine. METHODS: Immunologic anomalies were identified at baseline, before treatment with the masked medication, in a homogeneous series of patients with dry eye syndrome, who were enrolled in a large European multicenter clinical trial (Cyclosporin A Dry Eye Study; Allergan, Irvine, CA). IC specimens were collected in 243 patients with moderate to severe keratoconjunctivitis sicca (KCS), with or without Sjogren's syndrome (SS). Fifty normal subjects were separately examined to provide normal control values. Specimens were analyzed in a masked manner by flow cytometry, using antibodies directed to markers of the immune system and/or apoptotic pathway: HLA DR, CD40, CD40 ligand, Fas, and APO2.7. Levels of expression were quantified, and results were compared with those obtained in the 50 normal patients. RESULTS: One hundred sixty-nine specimens were successfully interpreted at baseline, including 41% from patients with SS. A highly significant increase of HLA DR expression by conjunctival cells was found in KCS-affected eyes compared with normal eyes, which did not express this marker or did so very weakly. HLA DR expression in eyes with SS was significantly higher than in KCS-affected eyes without SS. Fas and APO2.7 were found at low levels in all normal and KCS-affected eyes. CD40 and CD40 ligand expressions were significantly increased in eyes with KCS compared with normal eyes. HLA DR, CD40 and Fas were found at significantly higher levels in the SS group than in the non-SS group. CONCLUSIONS. Conjunctival cells from patients with dry eye with moderate to severe KCS, with or without SS, overexpress inflammatory and apoptosis-related markers. Whether inflammation is a primary phenomenon in KCS or is the consequence of repetitive abrasion of the ocular surface after tear film deficiency remains to be determined. These data, nevertheless, support the use of immunomodulatory and/or anti-inflammatory drugs in the treatment of patients with KCS.


Subject(s)
Biomarkers/analysis , Conjunctiva/metabolism , Epithelial Cells/metabolism , Eye Proteins/metabolism , Flow Cytometry , Keratoconjunctivitis Sicca/metabolism , Xenopus Proteins , Adolescent , Adult , Aged , Aged, 80 and over , CD40 Antigens/metabolism , CD40 Ligand , Conjunctiva/drug effects , Cyclosporine/therapeutic use , Double-Blind Method , Epithelial Cells/drug effects , Female , Fluorescent Antibody Technique, Indirect , HLA-DR Antigens/metabolism , Homeodomain Proteins/metabolism , Humans , Immunosuppressive Agents/therapeutic use , Keratoconjunctivitis Sicca/drug therapy , Male , Membrane Glycoproteins/metabolism , Middle Aged , fas Receptor/metabolism
10.
J Fr Ophtalmol ; 23(2): 111-21, 2000 Feb.
Article in French | MEDLINE | ID: mdl-10705112

ABSTRACT

PURPOSE: To compare the toxicity of a short-time application of timolol with benzalkonium chloride (timolol-BAC+) and unpreserved timolol (timolol-BAC-) in an in vitro model of human conjunctival cells. METHODS: Chang's conjunctival cell line (ATCC CCL 20.2) was treated for 15min. with 0.1%, 0.25% or 0.4% timolol-BAC(+) or BAC(-) and then examined immediately or 24h later. Cell viability, chromatin condensation, mitochondrial mass and activity, free radicals production were studied by microplate cold light cytometry. Moreover, relative cell number was evaluated by crystal violet colorimetric test. In addition, cell size and the expression of an apoptotic marker Apo2.7 were studied by flow cytometry. RESULTS: Timolol-BAC(+) induced a rapid decrease in cell viability ranging from 40% immediately after treatment to 85% 24h later. A small, significantly less important decrease in cell viability was also observed with all tested concentrations of timolol-BAC(-). 24h after treatment with 0.25% timolol-BAC(+), the relative cell number was reduced by 55% whereas it did not vary after 0.25% timolol -BAC(-) treatment. Only timolol-BAC(+) induced chromatin condensation, decrease in mitochondrial membrane potential and cell size reduction. Moreover, cells treated with timolol-BAC(+) overexpressed the apoptotic marker Apo2.7. Also reactive oxygen species (ROS) production was significantly more important after cell exposure to timolol-BAC(+). CONCLUSION: In our model of conjunctival cells in vitro, timolol-BAC(+) induced irreversible cytotoxic damage with some characteristics of apoptosis. The active compound of timolol-BAC(-) could be responsible for ROS production and for cell viability variations. Oxidative stress could also play a role in timolol-BAC(+)-induced toxicity. In vitro toxic effects of antiglaucoma drugs could, in part, explain some ocular surface disorders in long-term treated patients.


Subject(s)
Adrenergic beta-Antagonists/toxicity , Benzalkonium Compounds/toxicity , Cell Survival/drug effects , Conjunctiva/drug effects , Preservatives, Pharmaceutical/toxicity , Timolol/toxicity , Apoptosis/drug effects , Cell Count , Cells, Cultured , Conjunctiva/cytology , Dose-Response Relationship, Drug , Flow Cytometry , Humans , In Vitro Techniques , Ophthalmic Solutions
11.
Curr Eye Res ; 20(2): 85-94, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10617908

ABSTRACT

PURPOSE: To compare the toxicity of a short-time application of timolol with benzalkonium chloride (timolol-BAC+) and unpreserved timolol (timolol-BAC-) in a human conjunctival cell line. METHODS: Chang's conjunctival cell line (ATCC CCL 20.2) was treated for 15min. with 0.1%, 0.25% or 0.4% timolol-BAC(+) or BAC(-) and then examined immediately or 24h later. Cell viability, chromatin condensation and free radicals production were studied by microplate cold light cytometry. Moreover, relative cell number was evaluated by crystal violet colorimetric test. The comparison was done with an oxidative stress model of cells treated with 0.001-0.000001% hydrogen peroxide (H(2)O(2)). In addition, cell size and the expression of an apoptotic marker Apo2.7 were evaluated by flow cytometry. RESULTS: Timolol-BAC(+) induced a rapid decrease in cell viability ranging from 40% immediately after treatment to 85% 24h later. A small initial decrease in cell viability was also observed with all tested concentrations of timolol-BAC(-) but, 24h later, cell viability either tended to remain constant or cells completely recovered. Cell viability fell down after 24h exposure to 0.001% H(2)O( 2) whereas it was not modified at lower concentrations. 24h after treatment with 0.25% timolol-BAC(+), the relative cell number was reduced by 55% whereas it did not vary after 0.25% timolol-BAC(-) treatment. Only timolol-BAC(+) induced chromatin condensation and cell size reduction. Moreover, cells treated with timolol-BAC(+) overexpressed the apoptotic marker Apo2.7. Both timolol-BAC(+) and BAC(-) induced reactive oxygen species (ROS) production which was significantly more important when 0.25% or 0.4% timolol-BAC(+) were applied. Only 0.001% and 0.0001% H(2)O(2) generated a significant free radicals production. CONCLUSION: In our model of conjunctival cells in vitro timolol-BAC(+) induced irreversible cytotoxic damage with some characteristics of apoptosis. The active compound of timolol-BAC(-) could be responsible for reactive oxygen species production and for cell viability variations. The role of oxidative stress in timolol-BAC(+)-induced toxicity seems not to be predominant. in vitro toxic effects of antiglaucoma drugs could, in part, explain some ocular surface disorders in long-term treated patients.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , Benzalkonium Compounds/toxicity , Preservatives, Pharmaceutical/toxicity , Timolol/pharmacology , Cell Count/drug effects , Cell Line , Cell Survival/drug effects , Chromatin/drug effects , Chromatin/metabolism , Conjunctiva/cytology , Conjunctiva/drug effects , Dose-Response Relationship, Drug , Flow Cytometry , Free Radicals/metabolism , Glaucoma/prevention & control , Humans , Hydrogen Peroxide/pharmacology , Toxicity Tests
12.
Invest Ophthalmol Vis Sci ; 41(1): 120-6, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10634610

ABSTRACT

PURPOSE: CD40 antigen is a membrane receptor that plays a role in the regulation of immune reactions. The expressions of CD40 and CD40 ligand (CD40L) were investigated ex vivo and in vitro in conjunctival epithelial cells, in correlation with HLA DR class H antigen, previously shown to be upregulated in conjunctival inflammatory conditions. METHODS: Impression cytology specimens were collected in 186 patients: 52 normal ones, 65 with keratoconjunctivitis sicca, and 69 with chronic conjunctivitis. Cells were processed for flow cytometry, by using monoclonal antibodies to CD40, CD40L, and HLA DR antigens. Chang conjunctival cells were also used and treated with human recombinant interferon (IFN)-gamma or tumor necrosis factor (TNF)-alpha. CD40, CD40L, and HLA DR expressions were studied by flow cytometry after 24 and 48 hours of treatment. RESULTS: CD40 was found in both normal and pathologic eyes. Quantitation of levels of fluorescence showed a significantly higher expression in pathologic eyes than in normal ones (P < 0.0001). CD40L was variably and inconstantly expressed by conjunctival cells. A strong expression of HLA DR was observed in pathologic eyes, whereas normal eyes showed very low levels (P < 0.0001). Significantly positive correlations were found among CD40, CD40L, and HLA DR levels. Chang conjunctival cells expressed CD40 in basal conditions, whereas CD40L and HLA DR were negative. CD40 expression significantly increased after 24 hours of IFNgamma treatment and after 48 hours' exposure to TNFalpha. These cytokines had no effect on CD40L expression. HLA DR was upregulated after 24 hours of treatment with IFNgamma but remained negative after exposure to TNFalpha. CONCLUSIONS: Human conjunctival epithelial cells normally express CD40 antigen, and, more inconsistently, CD40L. Flow cytometry showed higher expression of these molecules in inflammatory eyes than in normal ones in correlation with class II antigen expression, as well as CD40 and HLA DR upregulation after treatment with proinflammatory cytokines in vitro.


Subject(s)
Antigens, Differentiation, T-Lymphocyte/metabolism , CD40 Antigens/metabolism , Conjunctiva/metabolism , Conjunctivitis/metabolism , Keratoconjunctivitis Sicca/metabolism , Membrane Glycoproteins/metabolism , Adult , Aged , Aged, 80 and over , CD40 Ligand , Cell Line , Chronic Disease , Conjunctiva/cytology , Conjunctiva/drug effects , Conjunctivitis/pathology , Epithelium/drug effects , Epithelium/metabolism , Flow Cytometry , HLA-DR Antigens/metabolism , Humans , Interferon-gamma/pharmacology , Keratoconjunctivitis Sicca/pathology , Ligands , Middle Aged , Recombinant Proteins , Tumor Necrosis Factor-alpha/pharmacology
13.
J Fr Ophtalmol ; 22(9): 950-8, 1999 Nov.
Article in French | MEDLINE | ID: mdl-10609169

ABSTRACT

PURPOSE: Ophthalmic preparations can induce conjunctival toxicity, often caused by preservatives. The aim of this study was to evaluate in vitro cytotoxicity of quaternary ammonium. METHODS: Cytotoxicity tests were done on a continuous human conjunctival cell line using microplate cold light cytofluorimetry. Membrane integrity (neutral red test), DNA condensation (Hoechst 33342 test) and reactive oxygen species (ROS) production (dichlorofluorescein diacetate and hydroethidine tests) were evaluated on living cells treated with different concentrations of benzalkonium chloride, benzododecinium bromide and cetrimide (0.00001 to 0.01%) after 15 minutes of treatment or 15 minutes and 24 hours of cell recovery. RESULTS: All the compounds tested showed similar in vitro effects. Using the neutral red test, we observed a decrease in membrane integrity even at 0.005% and 0.01% (p < 0.001) and after a short time (15 minutes). A stimulation of ROS production (H2O2 and O2) was observed at 0.00001% and above (p < 0.001), associated with a chromatine condensation due to an apoptotic phenomenon. CONCLUSION: A necrotic phenomenon is suggested at high concentrations of quaternary ammonium preservatives whereas an apoptotic mechanism exists for lower concentrations. This toxicity observed in vitro can explain some of the ocular surface damage caused by long-term use of preserved eye-drops.


Subject(s)
Conjunctiva/drug effects , Epithelial Cells/drug effects , Ophthalmic Solutions/toxicity , Preservatives, Pharmaceutical/toxicity , Quaternary Ammonium Compounds/toxicity , Anti-Infective Agents, Local/toxicity , Apoptosis/drug effects , Benzalkonium Compounds/toxicity , Cell Line/drug effects , Cell Survival , Cetrimonium , Cetrimonium Compounds/toxicity , Chromatin/drug effects , Conjunctiva/cytology , Detergents/toxicity , Disinfectants/toxicity , Epithelial Cells/cytology , Humans , Neutral Red , Ophthalmic Solutions/pharmacology , Reactive Oxygen Species , Time Factors
15.
Invest Ophthalmol Vis Sci ; 40(10): 2199-212, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10476784

ABSTRACT

PURPOSE: The purpose of this study was to investigate the effect of interferon (IFN)gamma on cell viability, cell growth, and apoptosis and on expression of apoptotic and inflammation-related proteins in epithelial conjunctival cells in vitro. Some aspects of transduction pathways of IFNgamma-induced alterations were also investigated, especially the role of protein kinase C (PKC) and IFNgamma transcriptional factor STAT1. METHODS: A human conjunctival cell line was treated with different concentrations (30 and 300 U/ml) of human recombinant IFNgamma. After 24, 48, and 72 hours of treatment, cell viability and relative cell number were studied with 3-(4,5-dimethylthiazol-2yl)2,5-diphenyl tetrazolium bromide (MTT) and crystal violet colorimetric assays. The apoptotic process was sought by phase-contrast microscopy, 4',6'-diamidino-2-phenylindole dihydrochloride (DAPI) staining, and transmission electron microscopy and was confirmed by DNA electrophoresis and immunoblotting of poly(ADP-ribose) polymerase (PARP). The cell cycle and expression of apoptotic proteins Fas, bax, and p53; of inflammation-related proteins HLA-DR and intercellular adhesion molecule (ICAM)-1; and of IFNgamma signal-transducing factor STAT1 were evaluated by flow cytometry and/or western blot analysis. To investigate PKC-related transduction pathways, two PKC modulators, 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and staurosporine, were applied for 3 hours, followed by IFNgamma treatment for 72 hours. Moreover, the effects of PKC depletion were studied after a 24-hour application of TPA, also followed by IFNgamma treatment for 72 hours. Then, Fas, ICAM-1, and HLA-DR expressions were studied by flow cytometry. RESULTS: IFNgamma at 30 U/ml induced no change in cell cycle and in cell viability. Cell viability significantly decreased after 48 hours of treatment with 300 U/ml IFNgamma, associated with cell cycle alterations (decrease in number of cells in the S-M phase), apoptotic chromatin condensation and fragmentation, ladder pattern on DNA electrophoresis assay, and cleavage of PARP. Moreover, IFNgamma-treated cells overexpressed plasma membrane Fas, HLA-DR, and ICAM-1 in a dose- and time-dependent manner, and STAT1 in both nuclear and cytosolic cell fractions. Only 300 U/ml IFNgamma-treated cells overexpressed bax, whereas Bcl-2 and p53 proteins were not modified. HLA-DR and Fas were upregulated after addition of staurosporine or after PKC-depleting treatment and repressed with TPA. Staurosporine, PKC depletion, and TPA all enhanced ICAM-1 expression. CONCLUSIONS: In our model, IFNgamma induced expression of inflammatory molecules and apoptotic mediators, cell growth arrest, and apoptosis of Chang conjunctival cells. Moreover, our results suggest that activation of PKC is not involved in some IFNgamma cellular effects that possibly imply the upregulation and nuclear translocation of STAT1. IFNgamma-induced apoptosis could explain in part the recently reported coexistence of inflammation and programmed cell death in ocular surface inflammatory disorders such as Sjögren's syndrome.


Subject(s)
Apoptosis/drug effects , Conjunctiva/drug effects , Epithelial Cells/drug effects , HLA-DR Antigens/metabolism , Intercellular Adhesion Molecule-1/metabolism , Interferon-gamma/pharmacology , Proto-Oncogene Proteins c-bcl-2 , Blotting, Western , Cell Cycle/drug effects , Cell Division/drug effects , Cell Line , Cell Survival/drug effects , Conjunctiva/cytology , Conjunctiva/metabolism , DNA-Binding Proteins/metabolism , Dose-Response Relationship, Drug , Epithelial Cells/cytology , Epithelial Cells/metabolism , Fas Ligand Protein , Flow Cytometry , Humans , Membrane Glycoproteins/metabolism , Protein Kinase C/metabolism , Proto-Oncogene Proteins/metabolism , Recombinant Proteins , STAT1 Transcription Factor , Staurosporine/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Time Factors , Trans-Activators/metabolism , Tumor Suppressor Protein p53/metabolism , bcl-2-Associated X Protein
17.
Invest Ophthalmol Vis Sci ; 40(3): 619-30, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10067965

ABSTRACT

PURPOSE: The aim of this study was to investigate the action of benzalkonium chloride (BAC), used as a preservative in most ophthalmic topical solutions, on epithelial conjunctival cells in vitro. METHODS: A continuous human conjunctival cell line (Wong-Kilbourne derivative of Chang conjunctiva) was exposed to BAC solutions at various concentrations (0.1%-0.0001%) during a period of 10 minutes. Cells were examined before treatment and 3, 24, 48, and 72 hours later, after reexposure to normal cell culture conditions. Cell number and viability were assessed with crystal violet and 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide colorimetric assays. The expression of the apoptotic marker Apo 2.7, nuclear antigen p53, membrane proteins Fas and Fas ligand, and DNA content was studied by flow cytometry. Morphologic aspects of cell nuclei were analyzed on slides with a nucleic acid-specific dye, 4',6'-diamidino-2-phenylindole dihydrochloride. Cytoskeleton was labeled with a monoclonal anti-pancytokeratin antibody. In addition, apoptosis was measured by DNA electrophoresis assays in agarose gel. RESULTS: Cell exposure to 0.1% and 0.05% BAC induced cell lysis immediately after treatment. All cells (100%) treated with 0.01% BAC died in a delayed manner within 24 hours, with most of the characteristics of apoptosis (chromatin condensation and DNA fragmentation, reduction in cell volume, expression of the apoptotic marker Apo 2.7, and apoptotic changes in DNA content). Aliquots of 0.005%, 0.001%, 0.0005%, and 0.0001% BAC induced growth arrest and apoptotic cell death in a dose-dependent manner between 24 and 72 hours after treatment. The expressions of Fas and p53 did not vary after BAC treatment. Fas ligand was always negative. CONCLUSIONS: These results suggest that BAC induces cell growth arrest and death at a concentration as low as 0.0001%. The mode of BAC-induced cell death is dose-dependent. Cells die by necrosis after BAC treatment at high concentrations and by apoptosis if low concentrations of BAC are applied. This new aspect of in vitro toxicity of BAC could in part explain some ocular surface disorders observed in patients undergoing long-term topical treatments with preservative-containing drugs.


Subject(s)
Benzalkonium Compounds/pharmacology , Conjunctiva/drug effects , Epithelial Cells/drug effects , Preservatives, Pharmaceutical/pharmacology , Apoptosis/drug effects , Cell Count , Cell Division/drug effects , Cell Survival/drug effects , Cells, Cultured , Conjunctiva/cytology , Conjunctiva/metabolism , DNA/analysis , Dose-Response Relationship, Drug , Epithelial Cells/cytology , Epithelial Cells/metabolism , Fas Ligand Protein , Flow Cytometry , Humans , Membrane Glycoproteins/metabolism , Necrosis , Tumor Suppressor Protein p53/metabolism , fas Receptor/metabolism
18.
Ophthalmology ; 106(3): 556-63, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10080214

ABSTRACT

OBJECTIVES: To investigate conjunctival and trabecular specimens from patients with glaucoma according to the duration and number of drugs received before filtration surgery, and to confirm, in a complementary experimental model, the role of preservative by comparing the effects of preserved and nonpreserved timolol. STUDY DESIGN: Experimental animal and human tissue study. PARTICIPANTS: Paired specimens of conjunctiva and trabeculum were taken from 61 patients undergoing trabeculectomy. Twenty-six patients were treated with 2 or more drugs for at least 1 year; 30 had received a beta-blocker for more than 1 year and 5 underwent primary surgery. A second study was performed in 25 rats receiving topical solutions in both eyes for 1 month. INTERVENTION: Immunohistochemistry was performed in all biopsy specimens using 12 different monoclonal antibodies. Ocular structures from rats treated for 1 month with preserved 0.5% timolol, nonpreserved 0.5% timolol, or 0.01% benzalkonium chloride were similarly investigated in an experimental study. MAIN OUTCOME MEASURES: Inflammatory cell infiltrates and fibroblasts were evaluated in biopsies, as well as in animal specimens, together with histologic changes induced by the drugs applied. RESULTS: Twenty-four of 26 conjunctivae and 21 of 24 trabecular pieces from multitreated patients were found to be abnormally infiltrated by cells expressing inflammatory or fibroblastic markers or both. Nineteen of 30 conjunctivae and 9 of 22 trabeculums in the monotherapy group and only 1 of 5 specimens from the primary surgery group were abnormal. In rats, preserved timolol and benzalkonium similarly showed infiltrates together with toxic histopathologic changes as compared to the nonpreserved timolol and control groups. CONCLUSIONS: These two combined studies confirmed histopathologic effects of antiglaucomatous drugs on the conjunctiva and showed similar effects in the trabecular meshwork. The experimental study showed that benzalkonium chloride is at least, to a large part, responsible for these toxic or immunoinflammatory effects or both on the ocular structures.


Subject(s)
Adrenergic beta-Antagonists/adverse effects , Conjunctiva/drug effects , Dendritic Cells/pathology , Pilocarpine/adverse effects , Sympathomimetics/adverse effects , Trabecular Meshwork/drug effects , Administration, Topical , Adrenergic beta-Antagonists/therapeutic use , Adult , Aged , Aged, 80 and over , Animals , Benzalkonium Compounds/adverse effects , Conjunctiva/pathology , Drug Therapy, Combination , Female , Fibroblasts/pathology , Fluorescent Antibody Technique, Indirect , Glaucoma/drug therapy , Glaucoma/surgery , Humans , Male , Middle Aged , Ophthalmic Solutions/adverse effects , Ophthalmic Solutions/therapeutic use , Pilocarpine/therapeutic use , Preservatives, Pharmaceutical/adverse effects , Rats , Rats, Inbred BN , Sympathomimetics/therapeutic use , Trabecular Meshwork/pathology , Trabeculectomy
19.
J Fr Ophtalmol ; 21(4): 265-9, 1998 Apr.
Article in French | MEDLINE | ID: mdl-9759415

ABSTRACT

PURPOSE: To prospectively evaluate use of the laser flare meter the inflammatory response after phacoemulsification with four different types of intraocular lenses. METHODS: Measurements with the Kowa laser flare meter FC-500 were done before surgery and at 1, 6 and 21 days following standard phacoemulsification with corneal incision in 157 patients. The patients were randomized in four groups to receive HSM IOL (group I), foldable acrylic IOL (group II), foldable three-piece silicone (group III), and foldable single-piece silicone (group IV). RESULTS: Overall, mean flare values were increased at D1, and decreased rapidly to normal values at D21. Intragroup analysis showed a slight increase of flare value observed in the PMMA group (p = 0.0015) and silicone monobloc group (p = 0.001) at D21 compared to D0. There was no statistical difference found between D0 and D21 in the acrylic and the silicone three pieces groups. At D1, a significant increase of flare values was observed in the PMMA (28.9 ph/ms) and silicone three pieces (28.8 ph/ms) groups, as compared to silicone monobloc group (22 ph/ms). At D21, the acrylic group had a significantly lower mean value than PMMA and silicone monobloc groups. No statistical difference was observed between acrylic and three-piece silicone at D21. CONCLUSION: This study shows that the inflammation in the four groups was very low after phacoemulsification by a corneal incision and attempts to explain the impact of the incision length on the breakdown of blood-aqueous barrier.


Subject(s)
Blood-Aqueous Barrier , Cell Count/methods , Endophthalmitis/diagnosis , Lasers , Lens Implantation, Intraocular , Phacoemulsification , Postoperative Complications/diagnosis , Acrylic Resins , Coated Materials, Biocompatible , Heparin , Humans , Lenses, Intraocular/classification , Polymethyl Methacrylate , Prospective Studies , Reproducibility of Results , Silicones
20.
Exp Eye Res ; 67(6): 687-97, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9990333

ABSTRACT

Fas antigen (CD95) is a membrane receptor that plays a major role in induction of apoptosis. In surface conjunctival epithelial cells the expressions of Fas, Fas ligand, the apoptotic marker APO2.7 and of HLA DR class II antigen, a membrane marker known to be expressed in inflammatory conditions were investigated. Impression cytology specimens were collected in 65 patients: 20 normal ones, 15 contact lens wearers, 20 receiving chronic topical antiglaucoma treatment and 10 with nonspecific chronic conjunctivitis. Cells were processed for flow cytometry, using monoclonal antibodies to Fas, Fas ligand, APO2.7, HLA DR antigens and a negative isotypic control. Percentages of positive cells were recorded and levels of fluorescence quantified using fluorescent beads at standardized fluorescence intensities. In addition, a human conjunctival cell line was incubated with anti-Fas stimulating antibodies in order to test Fas-induced apoptosis in vitro. Fas was found in all specimens in most of the conjunctival cells, but quantitation of levels of fluorescence showed a significantly higher expression in pathologic eyes than in normal ones. Fas ligand and APO2.7 were variably expressed by conjunctival cells, but in a significantly higher percentage of cells in pathological eyes than in normal ones. In these eyes a strong expression of HLA DR was also observed, whereas normal eyes showed lowest levels. Highly significant correlations were found between Fas, Fas ligand, APO2.7 and HLA DR levels. Anti-Fas antibodies in vitro induced strong apoptosis in epithelial cells as confirmed by APO2.7 expression and DAPI staining. This study confirms that conjunctival epithelial cells normally express Fas antigen, and more inconstantly its ligand, as do corneal ones or keratinocytes. Fluorescence quantitation by flow cytometry showed much higher expression in inflammatory eyes than in normal ones, and demonstrated a strong correlation between apoptotic and inflammatory pathways in the ocular surface.


Subject(s)
Conjunctivitis/etiology , HLA-DR Antigens/metabolism , Membrane Glycoproteins/metabolism , Adult , Aged , Aged, 80 and over , Apoptosis/physiology , Cells, Cultured , Conjunctivitis/metabolism , Conjunctivitis/pathology , Epithelial Cells/metabolism , Epithelial Cells/pathology , Fas Ligand Protein , Flow Cytometry , Humans , Immunohistochemistry , Membrane Proteins/metabolism , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...